• Explore /
  • Poster
  • / Efficacy and safety of anlotinib in overall and disease-specific advanced gynecological cancer: A real-world study.

Efficacy and safety of anlotinib in overall and disease-specific advanced gynecological cancer: A real-world study.

Abstract Video & Slides Poster

Authors

null

Xinyi Hong

Southeast University, Nanjing, China

Xinyi Hong , Shanhu Qiu , Xia Wu , Sizhen Chen , Xiaoxiang Chen , Bei Zhang , Aiqin He , Ying Zhou , Yun Xu , Jianqing Wang , Yingchun Gao , Xizhong Xu , Li Sun , Yang Zhang , Libing Xiang , Jundong Zhou , Qun Guan , Bingwei Chen , Yang Shen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Other Gynecologic Cancer

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5608)

DOI

10.1200/JCO.2023.41.16_suppl.5608

Abstract #

5608

Poster Bd #

303

Abstract Disclosures

Similar Posters

First Author: Akshit Chitkara

First Author: Yuankai Shi

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Efficacy and safety of anlotinib with PD-1 inhibitors in the treatment of advanced hepatocellular carcinoma: A real-world study.

Efficacy and safety of anlotinib with PD-1 inhibitors in the treatment of advanced hepatocellular carcinoma: A real-world study.

First Author: Kehe Chen

First Author: Xi Guo